Elucidating the precise pharmacological system of motion (MOA) of naturally occurring compounds is often demanding. Whilst Tarselli et al. (60) produced the first de novo artificial pathway to conolidine and showcased this naturally transpiring compound effectively suppresses responses to the two chemically induced and inflammation-derived pain, th